Welcome to our dedicated page for MSLP news (Ticker: MSLP), a resource for investors and traders seeking the latest updates and insights on MSLP stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MSLP's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MSLP's position in the market.
MusclePharm Corporation (OTCMKTS: MSLP) has launched FitMiss Energy, a zero-calorie energy drink tailored for women, available exclusively on Amazon. Each can contains 200mg of caffeine, 100% RDI of Biotin, and 450mg of BCAA, offered in three flavors: Pineapple Coco, Mango Sunshine, and Watermelon Waterfall. This new product expands the FitMiss brand, which has been a leader in female performance segments. MusclePharm aims to provide healthier options while tapping into growing categories. The drink contains no artificial ingredients and is competitively priced.
MusclePharm Corporation (OTCPINK: MSLP) has announced a definitive agreement to increase its October 2021 offering by adding $3,081,875 in Senior Secured Notes, generating gross proceeds of approximately $2,465,500. The Notes, with a six-month maturity and a 20% Original Issue Discount, will be accompanied by five-year warrants for 22,013,393 shares at an exercise price of $0.2310. The funds will primarily support working capital and marketing for a new energy line. The private placement is expected to close around June 8, 2022, subject to customary conditions.
MusclePharm Corporation (OTCMKTS: MSLP) announced that CEO Ryan Drexler and CFO Sabina Rizvi will present at the LD Micro Invitational XII Conference on June 7, 2022, at 4:00 pm Pacific Time. MusclePharm, founded in 2006, is recognized for its sports nutrition and energy beverage products available in over 100 countries. The company aims to assist athletes and fitness enthusiasts in achieving their full potential through scientifically advanced and safe supplementation.
MusclePharm Corporation (OTCMKTS: MSLP) reported a 31% increase in revenue for Q1 2022, reaching $13.1 million. This marks the second consecutive quarter of margin improvements despite industry challenges. The gross margin improved to 11.5%, significantly up from previous quarters, while the MP Performance Energy drink line achieved over $1.1 million in sales during the quarter. The company anticipates reaching $30 million in annual sales by 2023, driven by upcoming product launches, including the FitMiss Energy line.
MusclePharm Corporation (OTCMKTS: MSLP) will announce its financial results for Q1 2022 on May 16, 2022, after market close. A conference call to discuss these results will take place on the same day at 1:30 PM PT (4:30 PM ET), accessible via U.S. and international dial-ins, with a replay option available. MusclePharm is known for its sports nutrition and lifestyle supplements and has a strong international presence, selling in over 100 countries.
MusclePharm Corporation (OTCMKTS: MSLP) reported $10.0 million in net revenue for Q4 2021 and $50.0 million for the full year. Operating expenses declined by $2.7 million (16%). The MP Performance Energy drink line sold over 1.4 million cans since its launch, achieving fourth-quarter energy margins of 35% and full-year margins of 45%. Despite industry supply chain challenges, the company maintains a focus on operational efficiency. Upcoming plans include a new whey protein drink line and ongoing partnerships with retailers like Costco and Amazon.
MusclePharm Corporation (OTCMKTS: MSLP) announces it will release its financial results for Q4 and full year 2021 on April 14, 2022. A conference call will follow at 1:30 pm PT (4:30 pm ET) for investors to discuss the operating results. The call can be accessed via phone or through a live webcast on the company's Investor Relations website, which will remain available for 30 days. MusclePharm is recognized for its global reach in sports nutrition and aims to support athletes and active individuals with scientifically advanced supplementation.
MusclePharm Corporation (OTCMKTS: MSLP) announced the launch of its new ready-to-drink whey protein drink line in the summer of 2022. The beverage will feature over 20g of protein, be sugar-free, and will be available in various flavors, expanding MusclePharm's footprint in the growing protein market. CEO Ryan Drexler expressed confidence in the product's potential, supported by a strategic partnership with a premier production firm. This initiative reflects the company's commitment to becoming a leader in the nutrition and beverage sector.
MusclePharm Corporation (OTCMKTS: MSLP) announced preliminary full year 2021 revenue of $49-50 million and forecasts a record first quarter 2022 revenue of $13-15 million. Fourth quarter 2021 revenue is approximately $9-10 million. Supply chain delays shifted some revenue to early 2022. Key achievements include the launch of reformulated protein products, expanded distribution on Amazon, and a partnership with Alliance Sales & Marketing for energy drinks. The company aims for growth through improved infrastructure and new product offerings.
FAQ
What is the market cap of MSLP (MSLP)?
